258 related articles for article (PubMed ID: 24657067)
1. Cost-effectiveness of revascularization for limb preservation in patients with end-stage renal disease.
Barshes NR; Kougias P; Ozaki CK; Goodney PP; Belkin M
J Vasc Surg; 2014 Aug; 60(2):369-374.e1. PubMed ID: 24657067
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of revascularization for limb preservation in patients with marginal functional status.
Barshes NR; Kougias P; Ozaki CK; Pisimisis G; Bechara CF; Henson HK; Belkin M
Ann Vasc Surg; 2014 Jan; 28(1):10-7. PubMed ID: 24332257
[TBL] [Abstract][Full Text] [Related]
3. Lower Extremity Revascularization in End-Stage Renal Disease.
Jones DW; Dansey K; Hamdan AD
Vasc Endovascular Surg; 2016 Nov; 50(8):582-585. PubMed ID: 27770080
[TBL] [Abstract][Full Text] [Related]
4. Costs of Real-Life Endovascular Treatment of Critical Limb Ischemia: Report from Poland-A European Union Country with a Low-Budget Health Care System.
Krzanowski M; Drelicharz L; Belowski A; Partyka L; Sumek-Brandys B; Ramakrishnan PK; Nizankowski R
Ann Vasc Surg; 2016 Feb; 31():111-23. PubMed ID: 26616505
[TBL] [Abstract][Full Text] [Related]
5. Tibial angioplasty for limb salvage in high-risk patients and cost analysis.
Werneck CC; Lindsay TF
Ann Vasc Surg; 2009; 23(5):554-9. PubMed ID: 19632085
[TBL] [Abstract][Full Text] [Related]
6. Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI) score correlates with the intensity of multimodal limb treatment and patient-centered outcomes in patients with threatened limbs managed in a limb preservation center.
Robinson WP; Loretz L; Hanesian C; Flahive J; Bostrom J; Lunig N; Schanzer A; Messina L
J Vasc Surg; 2017 Aug; 66(2):488-498.e2. PubMed ID: 28410924
[TBL] [Abstract][Full Text] [Related]
7. Determinants of midterm functional outcomes, wound healing, and resources used in a hospital-based limb preservation program.
Ramanan B; Ahmed A; Wu B; Causey MW; Gasper WJ; Vartanian SM; Reyzelman AM; Hiramoto JS; Conte MS
J Vasc Surg; 2017 Dec; 66(6):1765-1774. PubMed ID: 28823866
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, treatment, and outcomes of acute limb ischemia in the pediatric population.
Lim S; Javorski MJ; Halandras PM; Kuo PC; Aulivola B; Crisostomo P
J Vasc Surg; 2018 Jul; 68(1):182-188. PubMed ID: 29502995
[TBL] [Abstract][Full Text] [Related]
9. The inpatient costs related to revascularization of lower extremity artery disease in terms of amputation and mortality rates.
Alptekin GS; Erkul S; Akgul E; Cekirdekci A
Vascular; 2024 Jun; 32(3):653-660. PubMed ID: 36749662
[TBL] [Abstract][Full Text] [Related]
10. Analysis of wound healing time and wound-free period as outcomes after surgical and endovascular revascularization for critical lower limb ischemia.
Okazaki J; Matsuda D; Tanaka K; Ishida M; Kuma S; Morisaki K; Furuyama T; Maehara Y
J Vasc Surg; 2018 Mar; 67(3):817-825. PubMed ID: 29032905
[TBL] [Abstract][Full Text] [Related]
11. In-hospital outcomes in patients with critical limb ischemia and end-stage renal disease after revascularization.
Meyer A; Lang W; Borowski M; Torsello G; Bisdas T;
J Vasc Surg; 2016 Apr; 63(4):966-73. PubMed ID: 26843355
[TBL] [Abstract][Full Text] [Related]
12. Nationwide Trends in Hospital Outcomes and Utilization After Lower Limb Revascularization in Patients on Hemodialysis.
Garimella PS; Balakrishnan P; Correa A; Poojary P; Annapureddy N; Chauhan K; Patel A; Patel S; Konstantinidis I; Chan L; Agarwal SK; Jaar BG; Gidwani U; Matsushita K; Nadkarni GN
JACC Cardiovasc Interv; 2017 Oct; 10(20):2101-2110. PubMed ID: 29050629
[TBL] [Abstract][Full Text] [Related]
13. Cost Analysis of Initial Treatment With Endovascular Revascularization, Open Surgery, or Primary Major Amputation in Patients With Peripheral Artery Disease.
Tang L; Paravastu SCV; Thomas SD; Tan E; Farmer E; Varcoe RL
J Endovasc Ther; 2018 Aug; 25(4):504-511. PubMed ID: 29756521
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of the treatments for critical limb ischemia in the elderly population.
Peters CML; de Vries J; Redeker S; Timman R; Eijck GV; Steunenberg SL; Verbogt N; Ho GH; van Busschbach JJ; van der Laan L
J Vasc Surg; 2019 Aug; 70(2):530-538.e1. PubMed ID: 30922757
[TBL] [Abstract][Full Text] [Related]
15. Open Versus Endovascular Revascularization of Below-Knee Arteries in Patients With End-Stage Renal Disease and Critical Limb Ischemia.
Meyer A; Schilling A; Kott M; Rother U; Lang W; Regus S
Vasc Endovascular Surg; 2018 Nov; 52(8):613-620. PubMed ID: 30021493
[TBL] [Abstract][Full Text] [Related]
16. Management of lower extremity wounds in patients with peripheral arterial disease: a stratified conservative approach.
Chiriano J; Bianchi C; Teruya TH; Mills B; Bishop V; Abou-Zamzam AM
Ann Vasc Surg; 2010 Nov; 24(8):1110-6. PubMed ID: 21035703
[TBL] [Abstract][Full Text] [Related]
17. The financial burden of surgical and endovascular treatment of diabetic foot wounds.
Joret MO; Dean A; Cao C; Stewart J; Bhamidipaty V
J Vasc Surg; 2016 Sep; 64(3):648-55. PubMed ID: 27565588
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of angiosome and non-angiosome targeted revascularization in critical lower limb ischemia.
Kabra A; Suresh KR; Vivekanand V; Vishnu M; Sumanth R; Nekkanti M
J Vasc Surg; 2013 Jan; 57(1):44-9. PubMed ID: 23058724
[TBL] [Abstract][Full Text] [Related]
19. Determinants of Long-Term Outcomes and Costs in the Management of Critical Limb Ischemia: A Population-Based Cohort Study.
Mustapha JA; Katzen BT; Neville RF; Lookstein RA; Zeller T; Miller LE; Jaff MR
J Am Heart Assoc; 2018 Aug; 7(16):e009724. PubMed ID: 30369325
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of ulcer healing and amputation-free survival in patients with critical limb ischemia.
Furuyama T; Onohara T; Yamashita S; Yoshiga R; Yoshiya K; Inoue K; Morisaki K; Kyuragi R; Matsumoto T; Maehara Y
Vascular; 2018 Dec; 26(6):626-633. PubMed ID: 30003829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
